Department of Psychology, Palo Alto University, Palo Alto, California, USA.
Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
J Womens Health (Larchmt). 2021 Apr;30(4):525-532. doi: 10.1089/jwh.2020.8320. Epub 2020 Jun 29.
Pregnant women are at an increased risk for anxiety and depression, but a majority of women go untreated due to a high rate of undetected symptoms. The 4-item Patient Health Questionnaire (PHQ-4) is an ultrabrief screening instrument for anxiety and depression with sound psychometric properties demonstrated in the general population and primary care, but not among pregnant women. The aim of this study was to provide initial evidence of the validity and reliability of the PHQ-4 among pregnant women. Data from an international sample of 1148 pregnant women who participated in an online cross-sectional survey were examined using a confirmatory factor analysis (CFA) and multigroup analysis approaches. Average chronological and gestational ages were 27.7 years old (standard deviation [SD] = 6.5) and 16.8 weeks (SD = 10.6), respectively. Participants were from diverse cultural backgrounds and English and Spanish speaking ( = 587 and = 561, respectively). CFA reflected two distinct factors, which accounted for 59% of the proportion of variance in the two anxiety items and 50% in the two depression items. Coefficient values of 0.74 for anxiety and 0.70 for depression suggested good factor reliability. This is the first study demonstrating initial evidence supporting the validity and reliability of the PHQ-4 in pregnant women. Should this study be replicated, a clinical interview, which is the gold standard procedure, should be included. Regardless, the PHQ-4 may be a useful ultrabrief resource for maternal mental health clinicians and health care providers who need to identify potential cases of anxiety and depression in pregnant women using efficient and evidence-based tools.
孕妇患焦虑症和抑郁症的风险增加,但由于症状未被发现的比例较高,大多数女性未得到治疗。四项目病人健康问卷(PHQ-4)是一种超简短的焦虑和抑郁筛查工具,具有良好的心理测量学特性,已在普通人群和初级保健中得到证实,但在孕妇中尚未得到证实。本研究的目的是为 PHQ-4 在孕妇中的有效性和可靠性提供初步证据。
本研究使用验证性因子分析(CFA)和多组分析方法,对参加在线横断面调查的 1148 名孕妇的国际样本数据进行了检验。平均年龄为 27.7 岁(标准差 [SD] = 6.5)和 16.8 周(SD = 10.6)。参与者来自不同的文化背景,讲英语和西班牙语(分别为 = 587 和 = 561)。
CFA 反映了两个不同的因素,这两个因素分别解释了两个焦虑项目和两个抑郁项目中 59%和 50%的方差比例。焦虑的系数值为 0.74,抑郁的系数值为 0.70,表明因子可靠性良好。
这是第一项证明 PHQ-4 在孕妇中有效性和可靠性的初步证据的研究。如果这项研究得到复制,应该包括临床访谈,这是金标准程序。无论如何,PHQ-4 可能是孕产妇心理健康临床医生和医疗保健提供者有用的超简短资源,他们需要使用高效和基于证据的工具来识别孕妇中潜在的焦虑和抑郁病例。